Due to the increasing demand for high-quality viral clearance services, our site in Cologne, Germany, has increased capacity for these studies by more than 30%.
Performing sterility testing in isolators reduces the risk of a false-positive result. The use of decontamination procedures in isolators makes it important to consider VHP ingress testing to strengthen sterility testing results.
Charles River Microbial Solutions will now directly serve customers located in Israel, offering our full Microbial Solutions portfolio within this region.
Charles River is a flexible and easy-to-work-with partner throughout the entire antibody production process. We conduct comprehensive immunization protocols on a wide range of species, from SPF rodents to large animals.
Comprehensive preclinical assessment of stem cell therapies is critical for regulatory approval and to ensure safety in first-in-human clinical trials. Here are some tips to consider for a successful translational cell therapy program.
Bridge the gap from in vitro to in vivo models with our new European microinjection platform.
Discovery from Charles River has licensed a new model for Alzheimer’s disease in vivo studies.
Learn about ion channel trafficking effects and CiPA in our latest publication, featured in Scientific Reports.
Anterior segment optical coherence tomography (OCT) rounds out our ability to image the eye via a noninvasive method.
MEA technology facilitates stimulation and monitoring of neural circuits with a single chip.